206 related articles for article (PubMed ID: 37351172)
21. Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO
Zhu R; Wang Z; Liang P; He X; Zhuang X; Huang R; Wang M; Wang Q; Qian Y; Wang S
Acta Biomater; 2017 Nov; 63():163-180. PubMed ID: 28923539
[TBL] [Abstract][Full Text] [Related]
22. Lipoplex gene transfer of inducible nitric oxide synthase inhibits the reactive intimal hyperplasia after expanded polytetrafluoroethylene bypass grafting.
Pfeiffer T; Wallich M; Sandmann W; Schrader J; Gödecke A
J Vasc Surg; 2006 May; 43(5):1021-7. PubMed ID: 16678699
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues.
Ingram N; McVeigh LE; Abou-Saleh RH; Maynard J; Peyman SA; McLaughlan JR; Fairclough M; Marston G; Valleley EMA; Jimenez-Macias JL; Charalambous A; Townley W; Haddrick M; Wierzbicki A; Wright A; Volpato M; Simpson PB; Treanor DE; Thomson NH; Loadman PM; Bushby RJ; Johnson BRG; Jones PF; Evans JA; Freear S; Markham AF; Evans SD; Coletta PL
Theranostics; 2020; 10(24):10973-10992. PubMed ID: 33042265
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression.
Purdie KJ; Whitley GS; Johnstone AP; Cartwright JE
Cardiovasc Res; 2002 Jun; 54(3):659-68. PubMed ID: 12031712
[TBL] [Abstract][Full Text] [Related]
25. Trichloroethylene induce nitric oxide production and nitric oxide synthase mRNA expression in cultured normal human epidermal keratinocytes.
Shen T; Zhu QX; Yang S; Ding R; Ma T; Ye LP; Wang LJ; Liang ZZ; Zhang XJ
Toxicology; 2007 Oct; 239(3):186-94. PubMed ID: 17719164
[TBL] [Abstract][Full Text] [Related]
26. The prostaglandin agonist beraprost aggravates doxorubicin-mediated apoptosis by increasing iNOS expression in cardiomyocytes.
Lian WS; Chiou HC; Lin H; Chen JJ; Cheng CF
Curr Vasc Pharmacol; 2015; 13(1):54-63. PubMed ID: 23628005
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase.
Iwakiri Y
Clin Mol Hepatol; 2015 Dec; 21(4):319-25. PubMed ID: 26770919
[TBL] [Abstract][Full Text] [Related]
28. iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells.
De Boo S; Kopecka J; Brusa D; Gazzano E; Matera L; Ghigo D; Bosia A; Riganti C
Mol Cancer; 2009 Nov; 8():108. PubMed ID: 19925669
[TBL] [Abstract][Full Text] [Related]
29. Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits.
Hayashi T; Sumi D; Juliet PA; Matsui-Hirai H; Asai-Tanaka Y; Kano H; Fukatsu A; Tsunekawa T; Miyazaki A; Iguchi A; Ignarro LJ
Cardiovasc Res; 2004 Feb; 61(2):339-51. PubMed ID: 14736551
[TBL] [Abstract][Full Text] [Related]
30. Closed-loop trans-skull ultrasound hyperthermia leads to improved drug delivery from thermosensitive drugs and promotes changes in vascular transport dynamics in brain tumors.
Kim C; Guo Y; Velalopoulou A; Leisen J; Motamarry A; Ramajayam K; Aryal M; Haemmerich D; Arvanitis CD
Theranostics; 2021; 11(15):7276-7293. PubMed ID: 34158850
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide suppression of cellular proliferation depends on cationic amino acid transporter activity in cytokine-stimulated pulmonary endothelial cells.
Chicoine LG; Stenger MR; Cui H; Calvert A; Evans RJ; English BK; Liu Y; Nelin LD
Am J Physiol Lung Cell Mol Physiol; 2011 Apr; 300(4):L596-604. PubMed ID: 21239536
[TBL] [Abstract][Full Text] [Related]
32. The homeoprotein DLX4 controls inducible nitric oxide synthase-mediated angiogenesis in ovarian cancer.
Trinh B; Ko SY; Haria D; Barengo N; Naora H
Mol Cancer; 2015 Apr; 14():97. PubMed ID: 25924901
[TBL] [Abstract][Full Text] [Related]
33. Investigating the role of tumour cell derived iNOS on tumour growth and vasculature in vivo using a tetracycline regulated expression system.
Papaevangelou E; Whitley GS; Johnstone AP; Robinson SP; Howe FA
Int J Cancer; 2016 Jun; 138(11):2678-87. PubMed ID: 26756734
[TBL] [Abstract][Full Text] [Related]
34. Inducible nitric oxide synthase activity mediates TNF-α-induced endothelial cell dysfunction.
Liu C; Lei S; Cai T; Cheng Y; Bai J; Fu W; Huang M
Am J Physiol Cell Physiol; 2023 Sep; 325(3):C780-C795. PubMed ID: 37575057
[TBL] [Abstract][Full Text] [Related]
35. Activation of cytosolic phospholipase A2alpha through nitric oxide-induced S-nitrosylation. Involvement of inducible nitric-oxide synthase and cyclooxygenase-2.
Xu L; Han C; Lim K; Wu T
J Biol Chem; 2008 Feb; 283(6):3077-3087. PubMed ID: 18029351
[TBL] [Abstract][Full Text] [Related]
36. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells.
Iwashina M; Shichiri M; Marumo F; Hirata Y
Circulation; 1998 Sep; 98(12):1212-8. PubMed ID: 9743513
[TBL] [Abstract][Full Text] [Related]
37. [Inhibition of retrovirus-mediated gene transfer of inducible nitric oxide synthase on proliferation of vascular smooth muscle cell].
Zhang ZL; Han T
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 Nov; 25(4):506-10. PubMed ID: 21158045
[TBL] [Abstract][Full Text] [Related]
38. Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (S1177D) using ultrasound-enhanced destruction of plasmid-loaded microbubbles improves vasoreactivity.
Teupe C; Richter S; Fisslthaler B; Randriamboavonjy V; Ihling C; Fleming I; Busse R; Zeiher AM; Dimmeler S
Circulation; 2002 Mar; 105(9):1104-9. PubMed ID: 11877363
[TBL] [Abstract][Full Text] [Related]
39. Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers.
Pastorino F; Brignole C; Di Paolo D; Perri P; Curnis F; Corti A; Ponzoni M
Small; 2019 Mar; 15(10):e1804591. PubMed ID: 30706636
[TBL] [Abstract][Full Text] [Related]
40. Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice.
Deng S; Kruger A; Schmidt A; Metzger A; Yan T; Gödtel-Armbrust U; Hasenfuss G; Brunner F; Wojnowski L
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jul; 380(1):25-34. PubMed ID: 19308358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
